Vermedx Receives $500,000 Series A Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69a60bed-9e80-4f64-9c9d-551e26ce6a10&Preview=1 -
Date
5/1/2009 -
Company Name
Vermedx -
Mailing Address
371 Pearl St Burlington, VT 05401 -
Company Description
The American health care system is poorly equipped to effectively and cost-efficiently manage chronic disease in general, and diabetes in particular. With 40 million Americans affected by diabetes and related costs exceeding $100 billion annually, established treatment practices are simply not good enough.Vermedx programs embody the Chronic Care Model (CCM). This widely embraced approach to improving health outcomes emphasizes enabling provider teams to be prepared and proactive, and to interact regularly and effectively with well informed patients. It directly counteracts a leading factor in the current problem set: clinical inertia. -
Website
http://www.vermedx.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$500,000 -
Transaction Round
Series A -
Proceeds Purposes
FreshTracks Capital, a venture firm based in Shelburne, VT, led the financing, which is intended to provide Vermedx with funds to enhance marketing efforts and continue to develop products. -
M&A Terms
-
Venture Investor
Fresh Tracks Capital -
Venture Investor
Undisclosed
